Thomas BA - Singular Health CEO MD
| SHG Stock | 0.11 0.01 8.33% |
CEO
Thomas BA is CEO MD of Singular Health Group
| Address | 2/41 Discovery Drive, Bibra Lake, WA, Australia, 6163 |
| Phone | 1300 167 975 |
| Web | https://singular.health |
Singular Health Management Efficiency
The company has return on total asset (ROA) of (0.722) % which means that it has lost $0.722 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.83) %, meaning that it generated substantial loss on money invested by shareholders. Singular Health's management efficiency ratios could be used to measure how well Singular Health manages its routine affairs as well as how well it operates its assets and liabilities. Total Current Liabilities is likely to gain to about 1.1 M in 2024. Liabilities And Stockholders Equity is likely to gain to about 3 M in 2024Similar Executives
| Found 3 records | CEO Age | ||
| Craig McNally | Ramsay Health Care | 63 | |
| Pascal Roche | Ramsay Health Care | 62 | |
| Stuart Irving | Computershare | 53 | |
Management Performance
| Return On Equity | -3.83 | ||||
| Return On Asset | -0.72 |
Singular Health Group Leadership Team
Elected by the shareholders, the Singular Health's board of directors comprises two types of representatives: Singular Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Singular. The board's role is to monitor Singular Health's management team and ensure that shareholders' interests are well served. Singular Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Singular Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Martina Mariano, Chief Officer | ||
| Thomas Morrell, Chief Officer | ||
| Thomas BA, CEO MD | ||
| BCom BCom, Company Sec | ||
| Denning Chong, MD, CoFounder | ||
| James Hill, Chief Officer | ||
| Kwang Tay, Ex Director |
Singular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Singular Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.83 | ||||
| Return On Asset | -0.72 | ||||
| Operating Margin | (3.31) % | ||||
| Current Valuation | 23.58 M | ||||
| Shares Outstanding | 242.52 M | ||||
| Shares Owned By Insiders | 45.13 % | ||||
| Price To Book | 17.22 X | ||||
| Price To Sales | 28.56 X | ||||
| Revenue | 90.83 K | ||||
| Gross Profit | (71.87 K) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Singular Stock Analysis
When running Singular Health's price analysis, check to measure Singular Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Health is operating at the current time. Most of Singular Health's value examination focuses on studying past and present price action to predict the probability of Singular Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Health's price. Additionally, you may evaluate how the addition of Singular Health to your portfolios can decrease your overall portfolio volatility.